Cas:1029769-23-0 2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one manufacturer & supplier

We serve Chemical Name:2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one CAS:1029769-23-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

Chemical Name:2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
CAS.NO:1029769-23-0
Synonyms:2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
Molecular Formula:C9H10N2OS
Molecular Weight:194.2535
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one Use and application,2,3,7-trimethyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one technical grade,usp/ep/jp grade.


Related News: Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.” 3-pyrazolylacetonitrile manufacturers Biocatalytic processing offers many advantages over using conventional metal catalysts. The superior enantio- and regioselectivity of enzymes results in higher yields of purer product—typically comprising just a single enantiomer that has been modified on only a specific site. methyl 4-acetyloxy-2-methyl-1-benzofuran-6-carboxylate suppliers AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. N-pyridin-3-ylpiperidine-3-carboxamide vendor & factory.